ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. ポスター発表

PET imaging of liver fibrosis in rats with 18F-FEDAC, a radiotracer for translocator protein (18 kDa)

https://repo.qst.go.jp/records/71726
https://repo.qst.go.jp/records/71726
90651afa-716e-4bc9-82cd-659fdfc7a0b1
Item type 会議発表用資料 / Presentation(1)
公開日 2015-06-17
タイトル
タイトル PET imaging of liver fibrosis in rats with 18F-FEDAC, a radiotracer for translocator protein (18 kDa)
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Hatori, Akiko

× Hatori, Akiko

WEKO 705866

Hatori, Akiko

Search repository
Yui, Joji

× Yui, Joji

WEKO 705867

Yui, Joji

Search repository
Xie, Lin

× Xie, Lin

WEKO 705868

Xie, Lin

Search repository
Kumata, Katsushi

× Kumata, Katsushi

WEKO 705869

Kumata, Katsushi

Search repository
Ogawa, Masanao

× Ogawa, Masanao

WEKO 705870

Ogawa, Masanao

Search repository
Zhang, Ming-Rong

× Zhang, Ming-Rong

WEKO 705871

Zhang, Ming-Rong

Search repository
羽鳥 晶子

× 羽鳥 晶子

WEKO 705872

en 羽鳥 晶子

Search repository
由井 譲二

× 由井 譲二

WEKO 705873

en 由井 譲二

Search repository
謝 琳

× 謝 琳

WEKO 705874

en 謝 琳

Search repository
熊田 勝志

× 熊田 勝志

WEKO 705875

en 熊田 勝志

Search repository
小川 政直

× 小川 政直

WEKO 705876

en 小川 政直

Search repository
張 明栄

× 張 明栄

WEKO 705877

en 張 明栄

Search repository
抄録
内容記述タイプ Abstract
内容記述 Objectives: Hepatic fibrosis is the wound response to the chronic hepatic injury caused by various factors (alcohol abuse, viral infection, cholestasis, etc), and progress to cirrhosis. The objective of this study was to noninvasively visualize and monitor the progression of hepatic fibrosis to cirrhosis using positron emission tomography (PET) with N-benzyl-N-methyl-2-[7,8-dihydro-7-(2-18F-fluoroethyl)-8-oxo-2-phenyl-9H-purin-9-yl]acetamide (18F-FEDAC), a radiotracer specific for translocator protein (18 kDa, TSPO), and to determine cellular sources enriching TSPO expression in the liver. Methods: Hepatic fibrosis in model rats induced by carbon tetrachloride (CCl4) was histologically evaluated. CCl4 (2 mL/kg, 50% olive oil) was injected intraperitoneally twice weekly for 2, 4, 6, or 8 weeks. The uptake of radioactivity in the rat livers was measured with PET after injection of 18F-FEDAC. Also immunohistochemical staining, ex vivo autoradiography, and qRT-PCR were performed to elucidate the relation among the radioactivity uptake, TSPO levels, and cellular sources enriching TSPO expression in damaged livers. Results: PET study showed the uptake of radioactivity accumulating in the livers increased significantly after 2, 4, 6, and 8 weeks CCl4 treatment (AUC0-30 min: 37.0 ± 1.1, 41.2 ± 1.4, 42.4 ± 1.4, and 44.2 ± 0.7, respectively) compared to control without treatment (29.9 ± 0.7). Immunohistochemical study exhibited TSPO expression mainly in macrophages and hepatic stellate cells (HSCs). Both macrophages and HSCs expressing TSPO increased with development of liver fibrosis. Ex vivo autoradiography and immunohistochemical staining showed good correlation between the distribution of radioactivity from 18F-FEDAC and the TSPO expression in damaged livers. The TSPO mRNA levels increased correspondingly with the liver damage levels (2, 4, 6, and 8 weeks CCl4 treatment; 2.2, 3.0, 6.5, and 4.6 fold, respectively) compared with the control group. Conclusions: PET imaging with 18F-FEDAC represented the progression of hepatic fibrosis to cirrhosis through the enhanced TSPO signals in hepatic macrophages and HSCs.
A. Representative transverse PET/CT fusion images of rat livers. PET images were acquired between 0 and 30 min after injection of 18F-FEDAC to 2, 4, 6, or 8 weeks CCl4 treated and control rats. CCl4 (2 mL/kg, 50% sterile olive oil) was injected intraperitoneally for 2 times per week. The pseudocolor bar represents the level of 18F-FEDAC accumulation in the liver. B. Time-activity curves of livers. (n=4 for each group). C. Values of areas under the time-activity curves (AUC0-30 min, SUV min, mean ± SE) were calculated from the time-activity curves between 0 and 30 min. The values were increased at 2 weeks (1.2 fold), 4 weeks (1.4 fold), 6 weeks (1.4 fold), and 8 weeks (1.5 fold) of CCl4 treatment compared to control. A significant difference (p<0.05) was seen in the following comparisons, *: control versus CCl4 2, 4, 6, or 8 weeks treatment.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 SNMMI 2015 Annual Meeting に発表のための参加
発表年月日
日付 2015-06-07
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 19:48:04.096547
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3